Regulation of immune responses by TGF-β

Annual Review of Immunology

Volumn 16, Issue , 1998, Pages 137-161

  Letterio, John J ^a   Roberts, Anita B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Autoimmune disease; B cells; Dendritic cell; Macrophage; T cells

Indexed keywords

CYTOKINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL MODEL; AUTOCRINE EFFECT; AUTOIMMUNE DISEASE; DENDRITIC CELL; DISEASE ASSOCIATION; EFFECTOR CELL; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; OPPORTUNISTIC INFECTION; PARASITOSIS; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; IMMUNITY, CELLULAR; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031944290     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.16.1.137     Document Type: Review

References (14)

1. Paul WE, Seder RA. 1994. Lymphocyte responses and cytokines. Cell 76:241-51
2. Ruscetti FW, Palladino MA. 1991. Transforming growth factor-beta and the immune system. Prog. Growth Factor Res. 3:159-75
3. Wahl SM. 1994. Transforming growth factor beta: the good, the bad, and the ugly. J. Exp. Med. 180:1587-90
4. McCartney-Francis NL, Wahl SM. 1994. Transforming growth factor beta: a matter of life and death. J. Leukocyte Biol. 55:401-9
5. Letterio JL, Roberts AB. 1997. TGF-β: a critical modulator of immune cell function. Clin. Immunol. Immunopathol. 84(3):244-50
6. Roberts AB, Sporn MB. 1990. The transforming growth factors-β. In Handbook of Experimental Pharmacology. Peptide Growth Factors and Their Receptors, ed. MB Sporn, AB Roberts, pp. 419-72. New York: Springer-Verlag
7. Attisano L, Wrana JL. 1996. Signal transduction by members of the transforming growth factor-beta superfamily. Cytokine Growth Factor Rev. 7:327-39
8. Sporn MB, Roberts AB. 1992. Autocrine secretion - 10 years later. Ann. Intern. Med. 117:408-14
9. Letterio JJ, Bottinger E. 1997. Studies in TGF-β knockout and dominant-negative type II receptor transgenic mice. Min. Electrolyte Metab. In press
10. Xie J, Gallagher G. 1992. Transforming growth factor-beta is not the major soluble immunosuppressor in the microenvironments of human breast rumours. Anti-cancer Res. 12:2117-21
11. Schiott A, Sjögren HO, Lindvall M. 1996. Monocyte-dependent costimulatory ef-feet of TGF-β1 on rat T-cell activation. Scand. J. Immunol. 44:252-60
12. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, Sporn MB, Fauci AS. 1986. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1037-50
13. Ahuja SS, Paliogianni F, Yamada H, Balow JE, Boumpas DT. 1993. Effect of transforming growth factor-beta on early and late activation events in human T cells. J. Immunol. 150:3109-18
14. Espevik T, Waage A, Faxvaag A, Shalaby MR. 1990. Regulation of interleukin2 and interleukin-6 production from T-cells: involvement of interleukin-1 beta and transforming growth factor-beta. Cell Immunol. 126:47-56